Reports
Reports
Sale
The global nootropics market attained USD 3.01 billion in 2023. The global nootropics industry is expected to grow at a CAGR of 14.6% in the forecast period of 2024-2032 to attain USD 10.28 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America has the highest number of nootropics consumers regionally and holds the major market share of nootropics. The U.S. Food and Drug Administration has classified non-prescription nootropics product under the Generally Regarded as Safe (GRAS) category, thereby easing market expansion. Hence, it is the home of the largest market players in the nootropics industry. Consumption of multi-vitamin tablets for improving functional abilities is fairly common among the population of this region. High awareness for cognitive health, the rise of self-directed buyers, and a growing population are some of the factors that drive the market dominance of North America. The Asia Pacific is expected to be the fastest growing market in the forecast period. Countries such as China and India have a great history of cognitive based natural drugs. Foreign investment in collaboration with regional players holds immense potential for the growth of the nootropics industry.
Nootropics are drugs or supplements that claim to improve cognitive function, specifically executive functions, memory, creativity, or motivation, in healthy individuals. These have been in the market for several decades, such as caffeine and multivitamins - substances approved by FDA as dietary supplements and classified as GRAS (generally regarded as safe). Currently, these products are being marketed and sold to academic and professional overachievers to augment their brain functions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is bifurcated by type into:
The market is segmented on the basis of distribution channel into:
The market is segregated on the basis of application into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Due to a highly competitive and challenging work environment, the market for brain boosters has witnessed a rise and is expected to grow in the forecast period. The rising demand for improved decision making in the sports industry and growing awareness with respect to mental health are also boosting the rise of the market for nootropics. Due to increasing awareness, rising disposable incomes, and increased demand for productivity, the market is expected to grow rapidly in emerging countries such as China and India. As cognitive enhancers made from natural and herbal substances have already been common in these areas historically, mergers between foreign and local companies are expected to push the market for nootropics in these areas forward. However, on the flip side, various side effects, addiction, lack of awareness, the stigma around visiting psychiatrists and neurologists in developing countries might impede the growth of the nootropics industry.
The report gives a detailed analysis of the following key players in the global nootropics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Indications |
|
Breakup by Dosage Form |
|
Breakup by Route of Administration |
|
Breakup by End User |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nootropics Market Overview
3.1 Global Nootropics Market Historical Value (2017-2023)
3.2 Global Nootropics Market Forecast Value (2024-2032)
4 Global Nootropics Market Landscape
4.1 Global Nootropics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nootropics Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indication
4.2.3 Analysis by End User
5 Global Nootropics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nootropics Market Segmentation
6.1 Global Nootropics Market by Type
6.1.1 Market Overview
6.1.2 Over the Counter
6.1.2.1 L-theanine
6.1.2.2 Creatine
6.1.2.3 Phenotropil
6.1.2.4 Others
6.1.3 Prescription
6.1.3.1 Ritalin
6.1.3.2 Adderall
6.1.3.3 Provigil
6.1.3.4 Piracetam
6.1.3.5 Others
6.2 Global Nootropics Market by Indications
6.2.1 Market Overview
6.2.2 Productivity and Study
6.2.3 Socializing
6.2.4 Exercise and Health
6.2.5 Wellbeing
6.2.6 Others
6.3 Global Nootropics Market by Dosage Form
6.3.1 Market Overview
6.3.2 Tablets
6.3.3 Capsules
6.3.4 Injections
6.3.5 Others
6.4 Global Nootropics Market by Route of Administration
6.4.1 Market Overview
6.4.2 Oral
6.4.3 Parenteral
6.4.4 Others
6.5 Global Nootropics Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Specialty Clinics
6.5.4 Homecare
6.5.5 Others
6.6 Global Nootropics Market by Distribution Channel
6.6.1 Market Overview
6.6.2 Hospital Pharmacy
6.6.3 Retail Pharmacy
6.6.4 Online Pharmacy
6.6.5 Others
6.7 Global Nootropics Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Nootropics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nootropics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nootropics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nootropics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nootropics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 Pfizer Inc.
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 GlaxoSmithKline plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Novartis AG
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Mylan N.V.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Teva Pharmaceutical Industries Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Sanofi
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 AstraZeneca
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Johnson & Johnson Private Limited
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Cephalon A/S
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Reckitt Benckiser Group PLC
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Onnit Labs, Inc.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Mental Mojo, LLC
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 Noocube
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Opti-Nutra Ltd.
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 TruBrain
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
19 Global Nootropics Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
In 2023, the global nootropics market attained a value of nearly USD 3.01 billion.
The market is projected to grow at a CAGR of 14.6% between 2024 and 2032.
The major drivers of the market include the increasing awareness, rising disposable incomes, increased demand for productivity, rise of self-directed buyers, growing population, and foreign investment.
The rising demand for improved decision-making in the sports industry and growing awareness with respect to mental health are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Prescription and OTC are the types of nootropics in the market.
The market is segmented on the basis of distribution channels into online and offline.
Based on applications, the industry is divided into mood and depression, longevity and anti-ageing, sleep and recovery, memory enhancement, attention and focus, and anxiety, among others.
The major players in the industry are Purelife Bioscience Co., Ltd., UCB S.A., HVMN Inc., and Gaia Herbs, Inc., among others.
The global nootropics market attained a value of nearly USD 3.01 billion in 2023, driven by the rising demand for improved decision-making in the sports industry. Aided by rising disposable incomes and growing awareness with respect to mental health, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 14.6%.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Prescription and OTC are the types of nootropics in the market. The market is segmented on the basis of distribution channels into online and offline. Based on applications, the industry is divided into mood and depression, longevity and anti-ageing, sleep and recovery, memory enhancement, attention and focus, and anxiety, among others. The major regional markets for the nootropics are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are Purelife Bioscience Co., Ltd., UCB S.A., HVMN Inc., and Gaia Herbs, Inc., among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.